Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

the Objective of This Research is to Compare the Clinical Effectiveness of the Conventional Lingual Arch Space Maintainers With Three-dimensional Printed Space Maintainers.

12. mai 2026 oppdatert av: Reham Mohamed, Suez Canal University

Comparative Evaluation of the Conventional and Three-Dimensional Printed Lower Lingual Arch Space Maintainers A Randomized Clinical Trial

the objective of this research is to compare the clinical effectiveness of the conventional lingual arch space maintainers with three-dimensional printed space maintainers.

Studieoversikt

Detaljert beskrivelse

Introduction and Review of literature Primary teeth serve to preserve inborn space until permanent teeth erupt, in addition they help with speech and mastication. It is appropriate to highlight the primary dentition's function as the best space maintainer for permanent teeth. It is possible that premature primary tooth loss will cause undesirable primary and permanent tooth movements, including a loss in arch length. If there is not enough arch length, it is more likely to predict malocclusions such as crowding and ectopic eruption as well as tooth impaction.

Since the largest space loss occurs within a month of losing the deciduous teeth, it is best to use a space maintainer as soon as possible after early tooth loss. Space maintainers are the orthodontic appliance of choice for preventing space loss because they preserve space within the oral cavity.

Conventional space maintainers have significant drawbacks despite their clinical effectiveness. These include the need for patient compliance, extended chairside times, multiple steps in the fabrication process, technique-sensitive impressions and lab procedures, solder failure, and caries formation at band margins.

These disadvantages in the conventional space maintainer recommend the need for more advanced appliance designs and materials, one of which is three-dimensional (3D) printing, The process involves creating 3D objects using a digitally scanned and layered design of the entire object. The design is preserved using a "Standard Tessellation Language" (STL) file.

So, the objective of this research is to compare the clinical effectiveness of the conventional lingual arch space maintainers with three-dimensional printed space maintainers.

Studietype

Intervensjonell

Registrering (Antatt)

44

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studer Kontakt Backup

Studiesteder

    • Ismailia Governorate
      • Ismailia, Ismailia Governorate, Egypt, 41522
        • Rekruttering
        • Suez Canal University
        • Ta kontakt med:
        • Ta kontakt med:
          • Rim M. Co-investigator, Lecturer

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Barn

Tar imot friske frivillige

Nei

Beskrivelse

Inclusion Criteria:

  • Apparently, healthy cooperative children have recently prematurely loss of more than one mandibular primary molar in any of the quadrants, full erupted mandibular first permanent molars in both sides, and whose lower permanent incisors have erupted
  • The permanent successors of the lost primary molars were not expected to erupt within 6 months
  • Angle's class 1 occlusion with normal primary molar relation
  • Caries-free and periodontally healthy abutment teeth
  • Absence of parafunctional habits or abnormal occlusion conditions such as crossbite, open bite, or deep bite.
  • Children's age ranges from 7 to 9 years-old
  • Radiographically, presence of permanent successors, more than one millimeter of bone covering the successor tooth germ, and/or only about one-third of the root of the permanent tooth has been formed.
  • Parents and children were accepting the new treatment modality.

Exclusion Criteria:

  • children exhibited poor oral hygiene, para-functional oral habits, severe crowding, space loss, and abnormal occlusion
  • Extraction of primary molars exceeding three months.
  • Radiographically, absence of permanent successor.
  • uncooperative children

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Aktiv komparator: Group I
Conventional spacemaintainer
Two bands will be selected and checked for fit and adaptation around the distal abutment teeth, then an alginate impression will be taken and will be sent to the laboratory for fabrication
Eksperimentell: Group II
3D printed spacemaintainer
An intraoral scan for the patients' lower arch will be taken using a 3D digital dental scanner.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Patient satisfaction and pain experienced using the Wong-Baker Faces Test
Tidsramme: 9 months
Patient satisfaction and pain experienced during conventional and digital impression and cementation will be evaluated using the Wong-Baker Faces test and subsequently recorded for clinical satisfaction at 3 months, 6 months and 9 months for both patient groups to evaluate appliance acceptance and convenience for the patients.
9 months
Gingival health will be evaluated using Sillness and Loe Gingival Index
Tidsramme: 9 months

gingival health will be evaluated by Sillness and Loe Gingival Index

Evaluation of the gingival health according to the (GI) described by (Loe and Silness, 1963):

Score Criteria for the Gingival Index 0 No inflammation.

  1. Mild inflammation: slight redness, slight edema, no bleeding on probing.
  2. Moderate inflammation: redness, edema, glazing, bleeding on probing.
  3. Severe inflammation: marked redness and edema, ulceration, and a tendency of spontaneous bleeding.
9 months

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Impression taking experience for the patient assessed by 6-questions survey
Tidsramme: Day 1

Questions Answer by Yes (√) or (No) ×

  1. Was the impression easy?
  2. Did you feel nausea during impression taking?
  3. Any malaise during impression taking ( bad taste,odour, foreign body)?
  4. Did impression take short time?
  5. Would you repeat this impression experience again?
  6. Did you feel any stress during impression taking?
Day 1

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

22. januar 2025

Primær fullføring (Antatt)

1. august 2026

Studiet fullført (Antatt)

1. september 2026

Datoer for studieregistrering

Først innsendt

21. desember 2025

Først innsendt som oppfylte QC-kriteriene

12. mai 2026

Først lagt ut (Faktiske)

15. mai 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

15. mai 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

12. mai 2026

Sist bekreftet

1. desember 2025

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • 930/2024
  • Organization's Unique Protocol (930/2024)

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

IPD-planbeskrivelse

may be after publishing

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

produkt produsert i og eksportert fra USA

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere